NKF(SH:603707) Shang Hai Zheng Quan Bao·2025-05-23 20:10Core Viewpoint - Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. has decided not to adjust the conversion price of its convertible bonds, despite triggering the downward adjustment clause due to stock prices falling below 90% of the current conversion price for 15 out of 30 trading days [2][7]. Group 1: Convertible Bond Details - The company issued 5,031,900 convertible bonds on April 23, 2020, with a total amount of 50.319 million yuan and a maturity of 6 years [3]. - The initial conversion price was set at 54.97 yuan per share, which has been adjusted to the latest price of 24.44 yuan per share [3][6]. - The conversion period for the bonds is from October 29, 2020, to April 22, 2026 [7]. Group 2: Price Adjustment History - The conversion price has undergone several adjustments due to various corporate actions, including stock incentive plans and profit distribution [4][5][6]. - Notable adjustments include a decrease from 54.97 yuan to 42.05 yuan due to the 2019 profit distribution and further adjustments down to 24.44 yuan as of July 8, 2024 [4][5][6]. Group 3: Decision on Price Adjustment - The board of directors held a meeting on May 23, 2025, and decided not to propose a downward adjustment of the conversion price, considering the long-term value of the company and the interests of all investors [2][7]. - The company will not propose any downward adjustment for the next six months, and any future decisions will be made after November 24, 2025, if the adjustment clause is triggered again [2][7].